An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction
Open Access
- 27 December 2005
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 203 (1) , 53-61
- https://doi.org/10.1084/jem.20051207
Abstract
Defective cardiac function during sepsis has been referred to as “cardiomyopathy of sepsis.” It is known that sepsis leads to intensive activation of the complement system. In the current study, cardiac function and cardiomyocyte contractility have been evaluated in rats after cecal ligation and puncture (CLP). Significant reductions in left ventricular pressures occurred in vivo and in cardiomyocyte contractility in vitro. These defects were prevented in CLP rats given blocking antibody to C5a. Both mRNA and protein for the C5a receptor (C5aR) were constitutively expressed on cardiomyocytes; both increased as a function of time after CLP. In vitro addition of recombinant rat C5a induced dramatic contractile dysfunction in both sham and CLP cardiomyocytes, but to a consistently greater degree in cells from CLP animals. These data suggest that CLP induces C5aR on cardiomyocytes and that in vivo generation of C5a causes C5a–C5aR interaction, causing dysfunction of cardiomyocytes, resulting in compromise of cardiac performance.Keywords
This publication has 53 references indexed in Scilit:
- Increased leakage of sarcoplasmic reticulum Ca2+ contributes to abnormal myocyte Ca2+ handling and shortening in sepsis*Critical Care Medicine, 2005
- Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsisThe FASEB Journal, 2003
- Neutrophil C5a receptor and the outcome in a rat model of sepsisThe FASEB Journal, 2003
- Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of SepsisThe American Journal of Pathology, 2002
- C5a receptor and thymocyte apoptosis in sepsisThe FASEB Journal, 2002
- Protective effects of anti‐C5a peptide antibodies in experimental sepsisThe FASEB Journal, 2001
- Protective effects of anti-C5a in sepsis-induced thymocyte apoptosisJournal of Clinical Investigation, 2000
- Effects of anti‐C5a monoclonal antibodies on oxygen use in a porcine model of severe sgifisEuropean Journal of Clinical Investigation, 1998
- The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivoInflammation Research, 1991
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.Journal of Clinical Investigation, 1985